PureTech Health (PRTC) Competitors $18.45 -0.15 (-0.78%) As of 03:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. ETNB, SDGR, JANX, VERA, TVTX, EWTX, EVO, BHVN, MESO, and ANIPShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include 89BIO (ETNB), Schrodinger (SDGR), Janux Therapeutics (JANX), Vera Therapeutics (VERA), Travere Therapeutics (TVTX), Edgewise Therapeutics (EWTX), Evotec (EVO), Biohaven (BHVN), Mesoblast (MESO), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Its Competitors 89BIO Schrodinger Janux Therapeutics Vera Therapeutics Travere Therapeutics Edgewise Therapeutics Evotec Biohaven Mesoblast ANI Pharmaceuticals 89BIO (NASDAQ:ETNB) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk. Do analysts rate ETNB or PRTC? 89BIO currently has a consensus price target of $26.43, suggesting a potential upside of 148.30%. PureTech Health has a consensus price target of $45.00, suggesting a potential upside of 143.85%. Given 89BIO's higher possible upside, analysts plainly believe 89BIO is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 89BIO 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.00PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more volatility and risk, ETNB or PRTC? 89BIO has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Does the media favor ETNB or PRTC? In the previous week, 89BIO had 3 more articles in the media than PureTech Health. MarketBeat recorded 6 mentions for 89BIO and 3 mentions for PureTech Health. 89BIO's average media sentiment score of 0.75 beat PureTech Health's score of 0.31 indicating that 89BIO is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 89BIO 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PureTech Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is ETNB or PRTC more profitable? PureTech Health's return on equity of 0.00% beat 89BIO's return on equity.Company Net Margins Return on Equity Return on Assets 89BION/A -81.44% -70.17% PureTech Health N/A N/A N/A Do institutionals & insiders hold more shares of ETNB or PRTC? 0.0% of PureTech Health shares are held by institutional investors. 2.6% of 89BIO shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings & valuation, ETNB or PRTC? PureTech Health has higher revenue and earnings than 89BIO. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio89BION/AN/A-$367.08M-$3.38-3.15PureTech Health$4.83M91.77$27.78MN/AN/A SummaryPureTech Health beats 89BIO on 7 of the 13 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$443.27M$2.93B$5.50B$9.40BDividend YieldN/A2.46%4.25%4.09%P/E RatioN/A20.2928.1319.86Price / Sales91.77259.75424.9198.68Price / Cash7.5342.3835.5357.53Price / Book1.087.808.235.71Net Income$27.78M-$55.11M$3.24B$257.80M7 Day Performance3.69%2.34%0.66%1.12%1 Month Performance-0.36%13.02%8.07%11.30%1 Year Performance-17.98%1.46%28.44%16.88% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health2.4794 of 5 stars$18.45-0.8%$45.00+143.8%-19.9%$443.27M$4.83M0.00100News CoverageETNB89BIO1.6639 of 5 stars$11.12+1.1%$26.43+137.7%+15.3%$1.62BN/A-3.2940SDGRSchrodinger1.8084 of 5 stars$21.14+0.6%$32.75+54.9%-11.5%$1.55B$207.54M-8.04790Positive NewsAnalyst ForecastJANXJanux Therapeutics2.1834 of 5 stars$26.18+4.1%$91.89+251.0%-41.8%$1.55B$9.34M-19.2530News CoverageVERAVera Therapeutics4.1274 of 5 stars$23.78-0.2%$65.00+173.3%-36.7%$1.52BN/A-7.9340TVTXTravere Therapeutics3.7642 of 5 stars$16.91+2.7%$32.14+90.1%+63.0%$1.50B$233.18M-6.02460News CoveragePositive NewsAnalyst RevisionEWTXEdgewise Therapeutics1.481 of 5 stars$13.93+0.7%$40.00+187.2%-38.6%$1.47BN/A-8.9960EVOEvotec1.9406 of 5 stars$4.12+1.2%$5.93+44.0%-11.7%$1.46B$862.40M0.004,827News CoverageBHVNBiohaven3.3595 of 5 stars$14.18+1.8%$58.46+312.2%-64.8%$1.45BN/A-1.52239News CoverageMESOMesoblast2.4742 of 5 stars$11.17+0.5%$18.00+61.1%+48.0%$1.43B$5.90M0.0080News CoveragePositive NewsGap UpANIPANI Pharmaceuticals3.7569 of 5 stars$65.19+0.4%$78.88+21.0%+3.7%$1.41B$674.07M-51.33600Analyst Revision Related Companies and Tools Related Companies ETNB Alternatives SDGR Alternatives JANX Alternatives VERA Alternatives TVTX Alternatives EWTX Alternatives EVO Alternatives BHVN Alternatives MESO Alternatives ANIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
